Jane Street’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
DM
B
VCM
GS
Jane Street's CDNA Position: Q1 2026 in Review
Jane Street reduced its CareDx (CDNA) stake by 42% in Q1 2026, selling an estimated $3.4M and leaving 250,351 shares worth $4.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3711.
Jane Street first reported a position in CDNA in Q3 2019 and has held it in 22 quarters since. The position peaked at $8.11M in Q4 2025. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Jane Street held 250,351 shares of CareDx worth $4.35M as of Q1 2026.
- Jane Street sold 179,878 CareDx shares in Q1 2026, an estimated $3.4M.
- CareDx made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3711 holding.
- Jane Street first reported a position in CareDx in Q3 2019 and has held it in 22 quarters since.
- Jane Street's CareDx position peaked at $8.11M in Q4 2025.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.